Novo Nordisk A/S (NVO) Revenue and Net Income History
Historical revenue, operating income and net income for Novo Nordisk A/S (NVO) over the last 10 years. The current TTM revenue for Novo Nordisk A/S as of April 20, 2018 is $16.96B.
|Medical||Large Cap Pharmaceutical||$115.408B||$16.962B|
|Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.|